D-1394-2019 Class II Terminated

Recalled by American Health Packaging — Columbus, OH

FDA drug recall D-1394-2019 was initiated by American Health Packaging on May 9, 2019 and is designated Class II. Reason for recall: GMP Deviations: Potential cross contamination due to cleaning procedure failure. The recall status is terminated (terminated Sep 30, 2020). Affected quantity: 15,386 cartons.

Recall details

Product Type
Drugs
Report Date
Jun 26, 2019
Initiation Date
May 9, 2019
Termination Date
Sep 30, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
15,386 cartons

Product description

Anastrozole Tablets, USP, 1mg, 30-count unit dose blisters per carton, Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC 60687-112-21.

Reason for recall

GMP Deviations: Potential cross contamination due to cleaning procedure failure.

Distribution pattern

Nationwide within the USA

Code information

Lot #: 175289A, 175286B, 175290B, Exp. 08/31/2019; 179906A, Exp. 03/31/2020; 183252A, Exp. 09/30/2020; 184611A, Exp. 11/30/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1394-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1394-2019. Report a data issue: hello@regdatalab.com.